What we're about
Upcoming events (1)
Here is a great way to learn.
Lets meet and share our analysis and thoughts about this stock.
The place and date for this Meetup will be defined later.
You are welcome to share your comments and thoughts here.
Acology Inc. executives announced today that they are expanding their Canadian operations in anticipation of the national referendum to legalize recreational cannabis.
Recent high-level meetings with industry insiders have convinced Acology executives that the timing for increasing an already strong presence in the Canadian medical cannabis industry is in its' and their investor's best interest. Acology has maintained offices and a distribution facility in Vancouver, BC for the past 3 years. Acology's signature product, the MedTainer(TM), is seen by many in the industry as the ideal solution for companies that are looking to package cannabis products in a child-safe, FDA approved multi-functional container. With close to 3 million unit sales Acology's Medtainer has made strong advances into wholesale and retail operations globally. Acology products are now sold by more than 4000 distributors worldwide. As added value to their growing customer list, and in light of their recent agreement, each MedTainer is now shipped with a 4-gram Boveda hydration packet inserted in each container. Boveda products have become a staple in the hydroponics industry. With Acology now acting as the marketing arm for the Minnesota-based company sales of both companies' associated products have increased exponentially.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company's websites are http://www.Acologyinc.com for the hospice and palliative care industry and http://www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to [masked] or call (844) ACOLOGY [masked]). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc.
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.
(c)2017 Market News Publishing Inc. All rights reserved. 2017/01/23
Stock recommendations and comments presented on in this Meetup do not represent recommendations on whether to buy, sell or hold shares of a particular stock. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal or corporate ownership, may influence or factor into an expert's stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation.